Bone marrow examination for metastatic tumor. Aspirate and biopsy

Gurmukh Singh, John R. Krause, Volker Breitfeld

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

A 6‐year experience with bone marrow aspirates and biopsies (96 cases) positive for metastatic carcinoma is reviewed. Marrow examination detected secondary carcinoma in 58 cases (60%) despite negative roentgenographic and/or bone scan examinations. Breast carcinoma was the most frequent primary site. The bone marrow biopsy was superior to the aspirate in finding carcinoma (97% vs. 72%). However, in an occasional case, tumor was found only in aspirate preparations. Both procedures should be considered complementary and are recommended in the marrow evaluation of patients with carcinoma.

Original languageEnglish (US)
Pages (from-to)2317-2321
Number of pages5
JournalCancer
Volume40
Issue number5
DOIs
StatePublished - Jan 1 1977

Fingerprint

Bone Marrow Examination
Bone Marrow
Carcinoma
Biopsy
Neoplasms
Breast Neoplasms
Bone and Bones

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Bone marrow examination for metastatic tumor. Aspirate and biopsy. / Singh, Gurmukh; Krause, John R.; Breitfeld, Volker.

In: Cancer, Vol. 40, No. 5, 01.01.1977, p. 2317-2321.

Research output: Contribution to journalArticle

Singh, Gurmukh ; Krause, John R. ; Breitfeld, Volker. / Bone marrow examination for metastatic tumor. Aspirate and biopsy. In: Cancer. 1977 ; Vol. 40, No. 5. pp. 2317-2321.
@article{b2066cc97bab4ec7bc4cb510d62f9fc4,
title = "Bone marrow examination for metastatic tumor. Aspirate and biopsy",
abstract = "A 6‐year experience with bone marrow aspirates and biopsies (96 cases) positive for metastatic carcinoma is reviewed. Marrow examination detected secondary carcinoma in 58 cases (60{\%}) despite negative roentgenographic and/or bone scan examinations. Breast carcinoma was the most frequent primary site. The bone marrow biopsy was superior to the aspirate in finding carcinoma (97{\%} vs. 72{\%}). However, in an occasional case, tumor was found only in aspirate preparations. Both procedures should be considered complementary and are recommended in the marrow evaluation of patients with carcinoma.",
author = "Gurmukh Singh and Krause, {John R.} and Volker Breitfeld",
year = "1977",
month = "1",
day = "1",
doi = "10.1002/1097-0142(197711)40:5<2317::AID-CNCR2820400546>3.0.CO;2-Z",
language = "English (US)",
volume = "40",
pages = "2317--2321",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Bone marrow examination for metastatic tumor. Aspirate and biopsy

AU - Singh, Gurmukh

AU - Krause, John R.

AU - Breitfeld, Volker

PY - 1977/1/1

Y1 - 1977/1/1

N2 - A 6‐year experience with bone marrow aspirates and biopsies (96 cases) positive for metastatic carcinoma is reviewed. Marrow examination detected secondary carcinoma in 58 cases (60%) despite negative roentgenographic and/or bone scan examinations. Breast carcinoma was the most frequent primary site. The bone marrow biopsy was superior to the aspirate in finding carcinoma (97% vs. 72%). However, in an occasional case, tumor was found only in aspirate preparations. Both procedures should be considered complementary and are recommended in the marrow evaluation of patients with carcinoma.

AB - A 6‐year experience with bone marrow aspirates and biopsies (96 cases) positive for metastatic carcinoma is reviewed. Marrow examination detected secondary carcinoma in 58 cases (60%) despite negative roentgenographic and/or bone scan examinations. Breast carcinoma was the most frequent primary site. The bone marrow biopsy was superior to the aspirate in finding carcinoma (97% vs. 72%). However, in an occasional case, tumor was found only in aspirate preparations. Both procedures should be considered complementary and are recommended in the marrow evaluation of patients with carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0017652111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017652111&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197711)40:5<2317::AID-CNCR2820400546>3.0.CO;2-Z

DO - 10.1002/1097-0142(197711)40:5<2317::AID-CNCR2820400546>3.0.CO;2-Z

M3 - Article

C2 - 922673

AN - SCOPUS:0017652111

VL - 40

SP - 2317

EP - 2321

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -